Yüklüyor......

IQGAP1 Protein Binds Human Epidermal Growth Factor Receptor 2 (HER2) and Modulates Trastuzumab Resistance

Human epidermal growth factor receptor 2 (HER2) is overexpressed in 20–25% of breast cancers. Increased HER2 expression is an adverse prognostic factor and correlates with decreased patient survival. HER2-positive (HER2(+)) breast cancer is treated with trastuzumab. Unfortunately, some patients are...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: White, Colin D., Li, Zhigang, Dillon, Deborah A., Sacks, David B.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Biochemistry and Molecular Biology 2011
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3191015/
https://ncbi.nlm.nih.gov/pubmed/21724847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M111.220939
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!